Pricing
Built with you, during the pilot.
TrialPilot is in its pilot program — and we want to work with any institution running clinical research, whatever its size. No tiers, no per-seat math: bring the trial in front of you and we'll stand it up on the platform together.
Pilot program
We're partnering, not price-listing.
Any institution, any size
Academic centers, biotech, CROs, and patient-led organizations are all welcome. We meet you where your research is.
Run a real study with us
Bring a protocol and we configure it, support your team through launch, and learn alongside you — your needs shape what we build next.
Invisible illness first
We are especially eager to partner with teams studying Long COVID, ME/CFS, Lyme, and dysautonomia — the conditions traditional trials reach last.
Beyond the pilot
Sustainability, support, and contracts.
Longer-term licensing, support agreements, and the commercial details are handled directly with our team, so we can tailor them to your program rather than a tier. Tell us what you're running and we'll take it from there.
Frequently asked questions
- What does it cost to join the pilot?
- During the pilot we're focused on partnering with institutions to run real studies, not on per-seat pricing. For longer-term licensing and support, talk to our team and we'll tailor it to your program.
- Who can take part?
- Any institution running clinical research — academic centers, biotech, CROs, and patient-led organizations. We are especially keen to support teams studying invisible and complex chronic illness.
- How do support and sustainability agreements work?
- Those are handled directly with our team so we can fit them to the size and shape of your program. Reach out via Contact sales and we'll walk through the specifics.
- How does TrialPilot ensure regulatory compliance?
- TrialPilot is built with FDA, ICH-GCP, and HIPAA in mind — automated audit trails (21 CFR Part 11), data-integrity controls, and CDISC-ready exports are part of the platform, not an add-on.